Wenbin Liang

Dr. Wenbin Liang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2019 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
PHPu Hong
Pu Hong
RGRuo-Nan Gu
Ruo-Nan Gu
FLFengxian Li
Fengxian Li
XXXiaoxing Xiong
Xiaoxing Xiong
WLWenbin Liang
Wenbin Liang
HZHong-Fei Zhang
Hong-Fei Zhang
The NLRP3 (nucleotide-binding oligomerization domain-like receptor [NLR] family pyrin domain-containing 3) inflammasome is a member of the NLR family of innate immune cell sensors. These are crucial regulators of cytokine secretions, which promote ischemic cell death and insulin resistance. This review summarizes recent progress regarding the NLRP3 inflammasome as a potential treatment for ischemic stroke in patients with diabetes, two complicated diseases that often occur together. Stroke worsens glucose metabolism abnormalities, and the outcomes after stroke are more serious for diabetic patients compared with those without diabetes. Inflammation contributes to organ injury after ischemic stroke and diabetes. Recent research has focused on inhibiting the activation of inflammasomes and thus reducing the maturation of proinflammatory cytokines such as interleukin (IL)-1β and IL-18. Studies suggest that inhibition of NLRP3 prevents or alleviates both ischemic stroke and diabetes. Targeting against the assembly and activity of the NLRP3 inflammasome is a potential and novel therapy for inflammasome-associated diseases, including ischemic stroke concomitant with diabetes.

24 October 2019 in Stem Cells
Verified
Journal Article
Open access
PDF file
WLWenbin Liang
Wenbin Liang
PHPengcheng Han
Pengcheng Han
EKElizabeth H. Kim
Elizabeth H. Kim
JMJordan Mak
Jordan Mak
RZRui Zhang
Rui Zhang
HCHee Cheol Cho
Hee Cheol Cho
Cardiac differentiation of embryonic stem cells (ESCs) can give rise to de novo chamber cardiomyocytes and nodal pacemaker cells. Compared with our understanding of direct differentiation toward atrial and ventricular myocytes, the mechanisms for nodal pacemaker cell commitment are not well understood. Taking a cue from the prominence of canonical Wnt signaling during cardiac pacemaker tissue development in chick embryos, we asked if modulations of Wnt signaling influence cardiac progenitors to bifurcate to either chamber cardiomyocytes or pacemaker cells. Omitting an exogenous Wnt inhibitor, which is routinely added to maximize cardiac myocyte yield during differentiation of mouse and human ESCs, led to increased yield of spontaneously beating cardiomyocytes with action potential properties similar to those of native sinoatrial node pacemaker cells. The pacemaker phenotype was accompanied by enhanced expression of genes and gene products that mark nodal pacemaker cells such as Hcn4, Tbx18, Tbx3, and Shox2. Addition of exogenous Wnt3a ligand, which activates canonical Wnt/β-catenin signaling, increased the yield of pacemaker-like myocytes while reducing cTNT-positive pan-cardiac differentiation. Conversely, addition of inhibitors of Wnt/β-catenin signaling led to increased chamber myocyte lineage development at the expense of pacemaker cell specification. The positive impact of canonical Wnt signaling on nodal pacemaker cell differentiation was evidenced in direct differentiation of two human ESC lines and human induced pluripotent stem cells. Our data identify the Wnt/β-catenin pathway as a critical determinant of cardiac myocyte subtype commitment during ESC differentiation: endogenous Wnt signaling favors the pacemaker lineage, whereas its suppression promotes the chamber cardiomyocyte lineage.

27 August 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
HLHong-Bin Lin
Hong-Bin Lin
FLFeng-Xian Li
Feng-Xian Li
JZJin-Yu Zhang
Jin-Yu Zhang
ZYZhi-Jian You
Zhi-Jian You
SXShi-Yuan Xu
Shi-Yuan Xu
HZHong-Fei Zhang
Hong-Fei Zhang
Cerebral-cardiac syndrome (CCS) refers to cardiac dysfunction following varying brain injuries. Ischemic stroke is strongly evidenced to induce CCS characterizing as arrhythmia, myocardial damage, and heart failure. CCS is attributed to be the second leading cause of death in the post-stroke stage; however, the responsible mechanisms are obscure. Studies indicated the possible mechanisms including insular cortex injury, autonomic imbalance, catecholamine surge, immune response, and systemic inflammation. Of note, the characteristics of the stroke population reveal a common comorbidity with diabetes. The close and causative correlation of diabetes and stroke directs the involvement of diabetes in CCS. Nevertheless, the role of diabetes and its corresponding molecular mechanisms in CCS have not been clarified. Here we conclude the features of CCS and the potential role of diabetes in CCS. Diabetes drives establish a “primed” inflammatory microenvironment and further induces severe systemic inflammation after stroke. The boosted inflammation is suspected to provoke cardiac pathological changes and hence exacerbate CCS. Importantly, as the key element of inflammation, NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome is indicated to play an important role in diabetes, stroke, and the sequential CCS. Overall, we characterize the corresponding role of diabetes in CCS and speculate a link of NLRP3 inflammasome between them.

28 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LGLara Gharibeh
Lara Gharibeh
AYAbir Yamak
Abir Yamak
JWJamieson Whitcomb
Jamieson Whitcomb
ALAizhu Lu
Aizhu Lu
MJMathieu Joyal
Mathieu Joyal
MNMona Nemer
Mona Nemer
Significance: GATA6 is a key regulator of sinus node (SAN) development. Loss of one Gata6 allele disrupts patterning and size of the SAN. GATA6 plays cell autonomous as well as non-cell autonomous functions in several cell types required for proper SAN development and function. Haploinsufficiency of Gata6 in mice leads to electrophysiological alterations and increases susceptibility to develop arrhythmias. GATA6 is critical for pacemaker cell differentiation and cardiac conduction.

12 November 2019 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
ALAizhu Lu
Aizhu Lu
CCCencen Chu
Cencen Chu
EMErin Mulvihill
Erin Mulvihill
RWRui Wang
Rui Wang
WLWenbin Liang
Wenbin Liang

1 April 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
ALAizhu Lu
Aizhu Lu
MKMaryam Kamkar
Maryam Kamkar
CCCencen Chu
Cencen Chu
JWJerry Wang
Jerry Wang
KGKaya Gaudet
Kaya Gaudet
WLWenbin Liang
Wenbin Liang